CA
CASI Pharmaceuticals, Inc.
CASIF · OTC
$0.15 +0.00% (+$0.00)
1M +27.50%
Market Cap $3.15M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.16x
P/E N/A
EV/EBITDA N/A
Growth
9 /100
Declining Rev. growth 1.84%
Book val. growth 72.02%
EPS growth N/A
Profitability
22 /100
Weak Gross margin 59.97%
Net margin 218.55%
Op. margin 190.98%
Quality
74 /100
Excellent ROIC 759.62%
ROA 208.70%
Asset turnover 0.95x
Debt
0 /100
High Current ratio 0.15x
Int. coverage -100.15x
Debt/Equity N/A
Stability
35 /100
Moderate Beta 1.40x
Rev. volatility 35.61%
EPS volatility 31.04%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CASIF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Cory
Employees
214
Headquarters
Beijing
Evenimente viitoare
13 NOV.
Earnings
Upcoming earnings report